NASDAQ : UNCY

Unicycive Therapeutics, Inc. — Earnings Estimates

$5.39 USD

$0.39 (7.8%)

Volume
1.5M
Average Volume
1.22M
Market Capitalization
$143.91M
P/E Ratio
-3.22
Dividend Yield
0.00%
Price Target
$22.00
Year High
$8.74
Year Low
$3.71
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$3.81

Annual earnings financials

UNCY financial data with annual/quarterly toggle

UNCY GAAP EPS - Annual & Quarterly

UNCY Sales Revenue - Annual & Quarterly

UNCY Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

UNCY Estimated and Actual Revenue by Quarter
UNCY Estimated and Actual EPS by Quarter
UNCY Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-30 3 8.16M 17.95M 13.05M 8.16M 17.95M 13.05M
2028-09-30 3 7.86M 17.28M 12.57M 7.86M 17.28M 12.57M
2028-06-30 3 7.25M 15.96M 11.6M 7.25M 15.96M 11.6M
2028-03-30 3 6.95M 15.29M 11.12M 6.95M 15.29M 11.12M
2027-12-30 4 15.49M 34.07M 24.78M 15.49M 34.07M 24.78M
2027-09-30 4 11.76M 25.87M 18.82M 11.76M 25.87M 18.82M
UNCY Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-30 3 - - - 184.13M 405.08M 294.6M
2028-09-30 3 - - - 177.31M 390.08M 283.69M
2028-06-30 3 - - - 163.67M 360.07M 261.87M
2028-03-30 3 - - - 156.85M 345.07M 250.96M
2027-12-30 4 31.59M 91.69M 61.64M 349.46M 768.82M 559.14M
2027-09-30 4 22.69M 65.86M 44.28M 265.42M 583.93M 424.68M
UNCY Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-30 3 40.79M 89.75M 65.27M 4 0 0 0
2028-09-30 3 39.28M 86.42M 62.85M 4 0 0 0
2028-06-30 3 36.26M 79.78M 58.02M 4 0 0 0
2028-03-30 3 34.75M 76.45M 55.6M 4 0 0 0
2027-12-30 4 77.43M 170.34M 123.88M 3 1.17362 3.40638 2.29
2027-09-30 4 58.81M 129.37M 94.09M 3 0.84306 2.44694 1.645